PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $378,031 | +2100072.2% | 174,208 | +1240.1% | 0.00% | – |
Q4 2022 | $18 | -99.9% | 13,000 | +8.3% | 0.00% | – |
Q2 2022 | $13,000 | -53.6% | 12,000 | -63.3% | 0.00% | – |
Q4 2021 | $28,000 | -83.4% | 32,700 | -73.4% | 0.00% | – |
Q3 2021 | $169,000 | -46.7% | 123,068 | -25.8% | 0.00% | – |
Q2 2021 | $317,000 | +3.6% | 165,806 | +144.2% | 0.00% | – |
Q1 2021 | $306,000 | +705.3% | 67,898 | +524.2% | 0.00% | – |
Q4 2020 | $38,000 | -17.4% | 10,878 | -7.8% | 0.00% | – |
Q3 2020 | $46,000 | -16.4% | 11,800 | -49.4% | 0.00% | – |
Q1 2020 | $55,000 | – | 23,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |